MR-guided radiotherapy for rectal cancer
Colorectal cancer is the third most common cancer in the UK, with rectal cancer accounting for approximately 20-30% of all cases and men being affected more than women. Treatment of rectal cancer is not only to prevent disseminated disease, but to reduce the risk of local recurrence (LR). Unfortunately LR causes significant morbidity and distress […]
Dr Manasi Ingle, Dr Shreerang Bhide
The Institute of Cancer Research